Compare MYGN & FUBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYGN | FUBO |
|---|---|---|
| Founded | 1991 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 444.2M | 284.3M |
| IPO Year | 1996 | 2011 |
| Metric | MYGN | FUBO |
|---|---|---|
| Price | $5.00 | $12.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $7.64 | ★ $28.40 |
| AVG Volume (30 Days) | 1.3M | ★ 4.7M |
| Earning Date | 05-05-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 48.08 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $771,400,000.00 | $4,271,000.00 |
| Revenue This Year | $6.89 | $45.37 |
| Revenue Next Year | $5.35 | $6.47 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 2.33 | ★ 10317.07 |
| 52 Week Low | $3.76 | $1.02 |
| 52 Week High | $8.59 | $14.21 |
| Indicator | MYGN | FUBO |
|---|---|---|
| Relative Strength Index (RSI) | 56.21 | 73.32 |
| Support Level | $4.23 | $3.17 |
| Resistance Level | $5.67 | $14.05 |
| Average True Range (ATR) | 0.29 | 1.07 |
| MACD | 0.07 | 0.06 |
| Stochastic Oscillator | 70.69 | 77.20 |
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
FuboTV Inc is a sports-first, live TV streaming company offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, FuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. It offers subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality suited to their preferences. The company has one operating segment, the streaming business. Geographically, the company generates a majority of its revenue from the United States and also has a presence in other markets.